Loading...
Loading...
Among the 2 tracked institutional investors we monitor, REVB (REVELATION BIOSCIENCES INC) is held with a combined value of $429.89K across 375,746 shares. The largest holder is ARMISTICE CAPITAL, LLC with a position worth $387.89K (0.01% of their portfolio). 2 funds opened new positions in the most recent quarter.
Total Institutional Value
$429.89K
Total Shares Held
375,746
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | $387.89K | 0.01% | New |
| 2 | VANGUARD GROUP INC | $42.00K | 0.00% | New |
| Member | Type | Date |
|---|---|---|
| Patrick J Toomey | Sell | Jul 31, 2019 |
| Patrick J Toomey | Sell | Jul 27, 2018 |
| Patrick J Toomey | Sell | Jun 25, 2018 |
| Patrick J Toomey | Sell |
As of the latest SEC 13F filings, ARMISTICE CAPITAL, LLC is the largest institutional holder of REVB with a position worth $387.89K, representing 0.01% of their portfolio. In total, 2 institutional investors hold REVB with a combined value of $429.89K.
In the most recent quarter, 2 funds opened a new position in REVB.
Institutional investors hold $429.89K worth of REVB stock across 2 positions. The largest institutional holder is ARMISTICE CAPITAL, LLC with $387.89K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For REVB, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their REVB positions.
| Jun 6, 2018 |
| Patrick J Toomey | Sell | Apr 30, 2018 |
| Patrick J Toomey | Sell | Mar 22, 2018 |
| Patrick J Toomey | Sell | Feb 8, 2018 |
| Patrick J Toomey | Sell | Jan 30, 2018 |
Showing 8 of 13. STOCK Act disclosures lag up to 45 days.
Last Close
$1.06
2026-07-24
YTD
-67.4%
1% of 52-week range